Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BOUNCE PLAY $INSY 7.651 -0.639 (-7.71%
$MJNA
$INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen $MYL https://globenewswire.com/news-release/2017/12/07/1247514/0/en/INSYS-Therapeutics-Starts-Proof-of-Concept-Study-of-Epinephrine-Nasal-Spray-for-Anaphylaxis.html
****In May 2018 FDA declared an EpiPen shortage across much of country. https://www.cbsnews.com/news/epipen-shortage-2018-05-09-fda/
$INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen $MYL https://globenewswire.com/news-release/2017/12/07/1247514/0/en/INSYS-Therapeutics-Starts-Proof-of-Concept-Study-of-Epinephrine-Nasal-Spray-for-Anaphylaxis.html
****In May 2018 FDA declared an EpiPen shortage across much of country. https://www.cbsnews.com/news/epipen-shortage-2018-05-09-fda/
$KNDI
(((((( $MJNA ))))))
(((((( $MJNA ))))))
((((( $INSY ))))))
((((( $INSY ))))))
GEVO Bid / ASK BOOOM Bid
4.09
Ask
4.10
B/A Size
7300x100
GEVO Bid / ASK BOOOM Bid
4.09
Ask
4.10
B/A Size
7300x100
* * $INSY Breaking out 8.32 + 0.1703 (2.09%) #Cannabis #Biotech
* * $INSY Breaking out 8.32 + 0.1703 (2.09%) #Cannabis #Biotech
$INSY INSYS Therapeutics License Partnership with Lunatus to Commercialize SUBSYS(R) (fentanyl sublingual spray) in the Middle East https://globenewswire.com/news-release/2018/05/08/1498861/0/en/INSYS-Therapeutics-Announces-Exclusive-License-Partnership-with-Lunatus-to-Commercialize-SUBSYS-fentanyl-sublingual-spray-in-the-Middle-East.html
$INSY INSYS Therapeutics License Partnership with Lunatus to Commercialize SUBSYS(R) (fentanyl sublingual spray) in the Middle East https://globenewswire.com/news-release/2018/05/08/1498861/0/en/INSYS-Therapeutics-Announces-Exclusive-License-Partnership-with-Lunatus-to-Commercialize-SUBSYS-fentanyl-sublingual-spray-in-the-Middle-East.html
$INSY INSYS Therapeutics, Inc. Top Institutional Holders
Holder Shares Date Reported % Out Value
Orbimed Advisors LLC. 5,406,844 Dec 30, 2017 7.33% 46,606,994
Blackrock Inc. 2,562,445 Dec 30, 2017 3.47% 22,088,275
Vanguard Group, Inc. (The) 2,537,086 Dec 30, 2017 3.44% 21,869,681
Mirae Asset Global Investments Co., Ltd. 1,470,996 Dec 30, 2017 1.99% 12,679,985
Norges Bank Investment Management 985,712 Dec 30, 2017 1.34% 8,496,837
State Street Corporation 455,221 Dec 30, 2017 0.62% 3,924,004
Dimensional Fund Advisors LP 434,548 Dec 30, 2017 0.59% 3,745,803
Northern Trust Corporation 312,227 Dec 30, 2017 0.42% 2,691,396
ETF Managers Group, LLC 282,268 Dec 30, 2017 0.38% 2,433,150
Geode Capital Management, LLC 245,665 Dec 30, 2017 0.33% 2,117,632
$INSY INSYS Therapeutics, Inc. Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 1,501,118 Jan 30, 2018 2.04% 15,206,325
iShares NASDAQ Biotechnology ETF 986,190 Jan 30, 2018 1.34% 9,990,104
Vanguard Small-Cap Index Fund 717,654 Jun 29, 2017 0.97% 8,949,145
Vanguard Total Stock Market Index Fund 640,836 Jun 29, 2017 0.87% 7,991,225
iShares Russell 2000 ETF 469,933 Jan 30, 2018 0.64% 4,760,421
Vanguard Small-Cap Growth Index Fund 369,022 Jun 29, 2017 0.50% 4,601,704
DFA U.S. Small Cap Series 329,164 Jul 30, 2017 0.45% 3,749,178
Vanguard Extended Market Index Fund 320,237 Jun 29, 2017 0.43% 3,993,355
iShares Russell 2000 Growth ETF 201,581 Jan 30, 2018 0.27% 2,042,015
Fidelity Select Portfolios - Biotechnology 123,605 Jan 30, 2018 0.17% 1,252,118
https://finance.yahoo.com/quote/INSY/holders?p=INSY
$INSY INSYS Therapeutics, Inc. Top Institutional Holders
Holder Shares Date Reported % Out Value
Orbimed Advisors LLC. 5,406,844 Dec 30, 2017 7.33% 46,606,994
Blackrock Inc. 2,562,445 Dec 30, 2017 3.47% 22,088,275
Vanguard Group, Inc. (The) 2,537,086 Dec 30, 2017 3.44% 21,869,681
Mirae Asset Global Investments Co., Ltd. 1,470,996 Dec 30, 2017 1.99% 12,679,985
Norges Bank Investment Management 985,712 Dec 30, 2017 1.34% 8,496,837
State Street Corporation 455,221 Dec 30, 2017 0.62% 3,924,004
Dimensional Fund Advisors LP 434,548 Dec 30, 2017 0.59% 3,745,803
Northern Trust Corporation 312,227 Dec 30, 2017 0.42% 2,691,396
ETF Managers Group, LLC 282,268 Dec 30, 2017 0.38% 2,433,150
Geode Capital Management, LLC 245,665 Dec 30, 2017 0.33% 2,117,632
$INSY INSYS Therapeutics, Inc. Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 1,501,118 Jan 30, 2018 2.04% 15,206,325
iShares NASDAQ Biotechnology ETF 986,190 Jan 30, 2018 1.34% 9,990,104
Vanguard Small-Cap Index Fund 717,654 Jun 29, 2017 0.97% 8,949,145
Vanguard Total Stock Market Index Fund 640,836 Jun 29, 2017 0.87% 7,991,225
iShares Russell 2000 ETF 469,933 Jan 30, 2018 0.64% 4,760,421
Vanguard Small-Cap Growth Index Fund 369,022 Jun 29, 2017 0.50% 4,601,704
DFA U.S. Small Cap Series 329,164 Jul 30, 2017 0.45% 3,749,178
Vanguard Extended Market Index Fund 320,237 Jun 29, 2017 0.43% 3,993,355
iShares Russell 2000 Growth ETF 201,581 Jan 30, 2018 0.27% 2,042,015
Fidelity Select Portfolios - Biotechnology 123,605 Jan 30, 2018 0.17% 1,252,118
https://finance.yahoo.com/quote/INSY/holders?p=INSY
$KNDI Kandi Technologies
Based out of Jinhua City, China, Kandi Technologies Group (and its subsidiary Zhejiang Kandi Vehicles Co., Ltd.) is recognized as one of China's top mechanical companies working on EV research, development, manufacturing, and sales. A member of the China Renewable Energy Auto Association, the company focuses primarily on all types of electric vehicles (EVs) as well as battery packs, all-terrain vehicles, and air-conditioning systems.
In the past few years, Kandi Technologies has shifted its focus to "pure EVs" ? or entirely electric vehicles. This means that their cars run entirely on electricity, unlike hybrid vehicles that include both an internal combustion engine and an electric motor.
In China, there is a huge push for "New Energy Vehicles" (NEVs) in order to cut down on urban pollution ? and commuter-centric cars like the ones Kandi produces may just be part of a viable solution. The Global Hawk K17AS, for example, a new model unveiled at the Global New Energy Vehicle Expo earlier this year, is the company's first attempt at an internet-enabled smart electric vehicle. The car comes equipped with a smart remote, in-vehicle 4G internet access, a 12.1-inch touch screen, a state-of-the-art "infotainment system," and uses Alibaba?s YunOS smartphone operating system.
http://mashable.com/2017/11/06/chinese-electric-car-companies/#uFaG0ugu.Pq9
$MJNA Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, U.S. Farmers as Sen. Mitch McConnell Pushes Bill to Legalize Hemp http://www.lelezard.com/en/news-16627042.html
$MJNA Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, U.S. Farmers as Sen. Mitch McConnell Pushes Bill to Legalize Hemp http://www.lelezard.com/en/news-16627042.html
$MJNA Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights - Annual Revenue Increased 230% Over 2016 https://www.medicalmarijuanainc.com/medical-marijuana-inc-reports-fourth-quarter-year-end-2017-financial-results-operational-highlights-annual-revenue-increased-230-2016/
$MJNA Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights - Annual Revenue Increased 230% Over 2016 https://www.medicalmarijuanainc.com/medical-marijuana-inc-reports-fourth-quarter-year-end-2017-financial-results-operational-highlights-annual-revenue-increased-230-2016/
$MJNA Medical Marijuana, Inc. Subsidiary Kannaway(R) Unveils New Hempy's(R) Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories
https://www.gurufocus.com/news/598892/medical-marijuana-inc-subsidiary-kannaway-announces-hempys--exclusive-responsibly-sourced-hemp-clothing-and-accessories
$MJNA Medical Marijuana, Inc. Subsidiary Kannaway(R) Unveils New Hempy's(R) Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories
https://www.gurufocus.com/news/598892/medical-marijuana-inc-subsidiary-kannaway-announces-hempys--exclusive-responsibly-sourced-hemp-clothing-and-accessories
$MJNA Men's Health Features Medical Marijuana, Inc. CEO in Article on Use of Cannabis for Workout Recovery
https://www.prnewswire.com/news-releases/mens-health-features-medical-marijuana-inc-ceo-in-article-on-use-of-cannabis-for-workout-recovery-300635994.html
$MJNA Men's Health Features Medical Marijuana, Inc. CEO in Article on Use of Cannabis for Workout Recovery
https://www.prnewswire.com/news-releases/mens-health-features-medical-marijuana-inc-ceo-in-article-on-use-of-cannabis-for-workout-recovery-300635994.html
$KNDI Kandi Pure EV Models K22 and K27 with Driving Range over 200km Receive MIIT Approvals https://www.nasdaq.com/press-release/kandi-pure-ev-models-k22-and-k27-with-driving-range-over-200km-receive-miit-approvals-20180523-00610
$KNDI Kandi Pure EV Models K22 and K27 with Driving Range over 200km Receive MIIT Approvals https://www.nasdaq.com/press-release/kandi-pure-ev-models-k22-and-k27-with-driving-range-over-200km-receive-miit-approvals-20180523-00610
7 Companies We'd Buy and Hold for the Next 20 Years
https://www.fool.com/investing/general/2016/03/12/7-companies-wed-buy-and-hold-for-the-next-20-years.aspx $DIS $CELG $KNDI $EPD $TSLA $PFE $AGN
7 Companies We'd Buy and Hold for the Next 20 Years
https://www.fool.com/investing/general/2016/03/12/7-companies-wed-buy-and-hold-for-the-next-20-years.aspx $DIS $CELG $KNDI $EPD $TSLA $PFE $AGN
$MJNA Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, garnered news coverage with a feature story in top national newspaper The Washington Post.
A March 28, 2018 article on The Washington Post’s website entitled “CBD is cannabis that won’t get you high. So why are so many people using it?” takes a deep dive into the story behind the rise in popularity of cannabidiol (CBD) in the United States. The article quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus and recognizes Medical Marijuana, Inc. as a producer of several CBD oils and products that entered the market in 2012.
Medical Marijuana, Inc. was the first company to ever create a global CBD pipeline with its flagship product, Real Scientific Hemp Oil™ (RSHO™), and now has several distribution subsidiaries such as HempMeds®, Kannaway® and Phyto Animal Health. The company also operates in many other countries around the world and was the first to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. The company has since set up distribution subsidiaries in those countries as well.
“We are thrilled to be acknowledged by such a prestigious national publication highlighting Medical Marijuana, Inc. as a leader in the CBD industry,” said Medical Marijuana, Inc. CEO Dr. Titus. “This kind of media coverage helps us communicate the health and wellness benefits of CBD, while shedding light on the company’s accomplishments.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
https://www.medicalmarijuanainc.com/top-u-s-newspaper-washington-post-features-medical-marijuana-inc-company-ceo-dr-stuart-titus/
$MJNA Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, garnered news coverage with a feature story in top national newspaper The Washington Post.
A March 28, 2018 article on The Washington Post’s website entitled “CBD is cannabis that won’t get you high. So why are so many people using it?” takes a deep dive into the story behind the rise in popularity of cannabidiol (CBD) in the United States. The article quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus and recognizes Medical Marijuana, Inc. as a producer of several CBD oils and products that entered the market in 2012.
Medical Marijuana, Inc. was the first company to ever create a global CBD pipeline with its flagship product, Real Scientific Hemp Oil™ (RSHO™), and now has several distribution subsidiaries such as HempMeds®, Kannaway® and Phyto Animal Health. The company also operates in many other countries around the world and was the first to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. The company has since set up distribution subsidiaries in those countries as well.
“We are thrilled to be acknowledged by such a prestigious national publication highlighting Medical Marijuana, Inc. as a leader in the CBD industry,” said Medical Marijuana, Inc. CEO Dr. Titus. “This kind of media coverage helps us communicate the health and wellness benefits of CBD, while shedding light on the company’s accomplishments.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
https://www.medicalmarijuanainc.com/top-u-s-newspaper-washington-post-features-medical-marijuana-inc-company-ceo-dr-stuart-titus/
$MJNA Medical Marijuana, Inc. Named a Top 3 Hemp Producer of 2018
https://www.medicalmarijuanainc.com/medical-marijuana-inc-named-top-3-hemp-producer-2018/
$MJNA Medical Marijuana, Inc. Named a Top 3 Hemp Producer of 2018
https://www.medicalmarijuanainc.com/medical-marijuana-inc-named-top-3-hemp-producer-2018/
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds(R) Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego https://www.epicos.com/article/152282/medical-marijuana-inc-subsidiary-hempmedsr-brasil-hold-its-second-doctor-symposium
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds(R) Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego https://www.epicos.com/article/152282/medical-marijuana-inc-subsidiary-hempmedsr-brasil-hold-its-second-doctor-symposium
$GEVO Book Value Per Share $54.25
$GEVO Book Value Per Share $54.25
$HEMP Hemp Inc. Undervalued Hemp Pipeline http://www.hempinc.com
$HEMP Hemp Inc. Undervalued Hemp Pipeline http://www.hempinc.com